首页 > 最新文献

Antibiotiki i Khimioterapiya最新文献

英文 中文
Non-Specific Means of Medical Protection Against COVID-19 针对COVID-19的非特异性医疗保护手段
Q4 Medicine Pub Date : 2023-10-20 DOI: 10.37489/0235-2990-2023-68-5-6-69-76
T. E. Sizikova, E. V. Lebedinskaya, O. V. Chukhralya, A. A. Petrov, V. N. Lebedev, S. V. Borisevich
At the beginning of 2020, humanity faced the pandemic of a novel coronavirus infection – COVID-19. The disease has become one of the most contagious for the entire history of mankind. Among medical means of protection, which can be used for prophylactics and treatment of COVID-19, non-specific medical medical protection means play an important role. The aim of this work is to analyze and evaluate the effectiveness of non-specific medical protection means against COVID-19. These medications are divided in two groups in accordance with the targets of their actions. The medications of the first group either block the virus from entering the cell, or inhibit the enzymes involved in viral RNA replication. The other group of medications affects the immune system of a macroorganism, which plays a crucial role in infection resistance, or blocks inflammatory processes in the lungs. Favipiravir is an example of a broad-spectrum antiviral drug with an established activity against SARS-CoV-2 in particular. During the development of new non-specific medical protection means against COVID-19, a comprehensive validation in representative randomized clinical trials is an important condition for their implementation in medical practice.
2020年初,人类面临着新型冠状病毒感染COVID-19的大流行。这种疾病已经成为整个人类历史上最具传染性的疾病之一。在预防和治疗新冠肺炎的医疗防护手段中,非特异性医疗防护手段发挥着重要作用。本研究的目的是分析和评估非特异性医疗防护手段对COVID-19的有效性。这些药物根据其作用目标分为两组。第一组药物要么阻止病毒进入细胞,要么抑制参与病毒RNA复制的酶。另一组药物影响大型生物的免疫系统,它在抵抗感染中起着至关重要的作用,或者阻止肺部的炎症过程。Favipiravir是广谱抗病毒药物的一个例子,特别是对SARS-CoV-2具有确定的活性。在新型非特异性医疗防护手段开发过程中,具有代表性的随机临床试验的全面验证是其在医疗实践中实施的重要条件。
{"title":"Non-Specific Means of Medical Protection Against COVID-19","authors":"T. E. Sizikova, E. V. Lebedinskaya, O. V. Chukhralya, A. A. Petrov, V. N. Lebedev, S. V. Borisevich","doi":"10.37489/0235-2990-2023-68-5-6-69-76","DOIUrl":"https://doi.org/10.37489/0235-2990-2023-68-5-6-69-76","url":null,"abstract":"At the beginning of 2020, humanity faced the pandemic of a novel coronavirus infection – COVID-19. The disease has become one of the most contagious for the entire history of mankind. Among medical means of protection, which can be used for prophylactics and treatment of COVID-19, non-specific medical medical protection means play an important role. The aim of this work is to analyze and evaluate the effectiveness of non-specific medical protection means against COVID-19. These medications are divided in two groups in accordance with the targets of their actions. The medications of the first group either block the virus from entering the cell, or inhibit the enzymes involved in viral RNA replication. The other group of medications affects the immune system of a macroorganism, which plays a crucial role in infection resistance, or blocks inflammatory processes in the lungs. Favipiravir is an example of a broad-spectrum antiviral drug with an established activity against SARS-CoV-2 in particular. During the development of new non-specific medical protection means against COVID-19, a comprehensive validation in representative randomized clinical trials is an important condition for their implementation in medical practice.","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"176 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135618026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
<i>Helicobacter pylori</i> Persistence in Patients with Peptic Ulcer Disease and Chronic Gastritis in the Treatment with Antibiotics and Acid-Suppressive Agents & lt; i&gt;幽门螺杆菌pylori&lt; / i&gt;消化性溃疡和慢性胃炎患者在抗生素和抑酸药物治疗中的持续性
Q4 Medicine Pub Date : 2023-09-12 DOI: 10.37489/0235-2990-2023-68-s-5-48
E. V. Golubkina
Background. Chronic gastritides still have no division into forms according to the data of the genotyping of Helicobacter pylori isolates. Monitoring the results of anti- Helicobacter pylori therapy cannot be limited to eradication, by taking into account the data on Helicobacter pylori detection in healthy individuals. Is increased acid production associated with the presence of virulent or nonvirulent strains? Objective. To search for the predominance of cagA or any allelic combination of vacA in the isolates from patients with mild and severe chronic gastritis and from those with peptic ulcer disease. To track the time course of changes in the disappearance and repeated gastric colonization with different Helicobacter pylori strains in patients with peptic ulcer disease immediately after anti- Helicobacter pylori therapy and 1.5–2 months later. To confirm or refute the fact that the increased acid production is associated with the presence of virulent Helicobacter pylori strains rather than with the persistence of nonvirulent strains. Methods. The Helicobacter pylori isolates from the gastric biopsy specimens taken from patients with chronic gastritis and peptic ulcer disease were genotyped for cagA and allelic combinations of vacA . The strains from patients who had received anti- Helicobacter pylori therapy were genotyped using the variable number tandem repeat (VNTR) method. Patients with an exacerbation of peptic ulcer disease and those wth an exacerbation of chronic pancreatitis with concomitant gastritis were compared from the level of acid production and from the belonging of Helicobacter pylori to virulent strains. Results. Patients with mild chronic gastritis were observed to have an abundance of nonvirulent allelic combination of vacAs2m2, which differed significantly from its frequency in both the patients with severe chronic gastritis and those with peptic ulcer disease. In the latter patients, the differences between the background bacteriological pattern and the pattern observed after 1.5–2 months had a high degree of significance; in these follow-up periods, in contrast to the control immediately after therapy, the number of eradications increased and the number of cagA-containing strains decreased due to the change of strains. Acid production was significantly higher in the patients with peptic ulcer disease than in those with chronic pancreatits and concomitant gastritis; the former patients show a statistically significant predominance of virulent strains; the latter patients had nonvirulent strains (at the same rate of Helicobacter pylori detection). Conclusion. Filling the blank spots in the study of helicobacteriosis remains relevant due to the progress of genetic methods in bacteriology and to the introduction of novel approaches to assessing the results of anti- Helicobacter pylori therapy.
背景。根据幽门螺杆菌分离株的基因分型资料,慢性胃胃炎仍无形态划分。监测抗幽门螺杆菌治疗的结果不能局限于根除,要考虑到健康个体的幽门螺杆菌检测数据。产酸量的增加是否与毒力菌株或非毒力菌株有关?目标。目的:探讨轻、重度慢性胃炎患者和消化性溃疡患者分离株中cagA或任何vacA等位基因组合的优势。目的:追踪消化性溃疡患者在抗幽门螺杆菌治疗后立即及1.5 ~ 2个月后不同幽门螺杆菌菌株在胃内消失和反复定植的时间变化。证实或驳斥这样一个事实:产酸量的增加与毒性幽门螺杆菌菌株的存在有关,而不是与非毒性菌株的持续存在有关。方法。从慢性胃炎和消化性溃疡患者的胃活检标本中分离出幽门螺杆菌,进行cagA和vacA等位基因组合的基因分型。采用可变数串联重复(VNTR)法对接受抗幽门螺杆菌治疗的患者的菌株进行基因分型。对消化性溃疡加重患者和慢性胰腺炎合并胃炎加重患者的产酸水平和幽门螺杆菌与毒性菌株的归属进行了比较。结果。在轻度慢性胃炎患者中,vacAs2m2的非毒性等位基因组合丰度明显高于重度慢性胃炎患者和消化性溃疡患者。后一组患者背景菌型与1.5 ~ 2个月后观察到的菌型差异有高度显著性;在这些随访期间,与治疗后立即对照相比,由于菌株的变化,根除数量增加,含caga的菌株数量减少。消化性溃疡患者的产酸量明显高于慢性胰腺炎合并胃炎患者;前一组患者表现出具有统计学意义的毒株优势;后者为无毒菌株(幽门螺杆菌检出率相同)。结论。由于细菌学遗传方法的进步和抗幽门螺杆菌治疗效果评估的新方法的引入,填补幽门螺杆菌病研究的空白仍然是相关的。
{"title":"&lt;i&gt;Helicobacter pylori&lt;/i&gt; Persistence in Patients with Peptic Ulcer Disease and Chronic Gastritis in the Treatment with Antibiotics and Acid-Suppressive Agents","authors":"E. V. Golubkina","doi":"10.37489/0235-2990-2023-68-s-5-48","DOIUrl":"https://doi.org/10.37489/0235-2990-2023-68-s-5-48","url":null,"abstract":"Background. Chronic gastritides still have no division into forms according to the data of the genotyping of Helicobacter pylori isolates. Monitoring the results of anti- Helicobacter pylori therapy cannot be limited to eradication, by taking into account the data on Helicobacter pylori detection in healthy individuals. Is increased acid production associated with the presence of virulent or nonvirulent strains? Objective. To search for the predominance of cagA or any allelic combination of vacA in the isolates from patients with mild and severe chronic gastritis and from those with peptic ulcer disease. To track the time course of changes in the disappearance and repeated gastric colonization with different Helicobacter pylori strains in patients with peptic ulcer disease immediately after anti- Helicobacter pylori therapy and 1.5–2 months later. To confirm or refute the fact that the increased acid production is associated with the presence of virulent Helicobacter pylori strains rather than with the persistence of nonvirulent strains. Methods. The Helicobacter pylori isolates from the gastric biopsy specimens taken from patients with chronic gastritis and peptic ulcer disease were genotyped for cagA and allelic combinations of vacA . The strains from patients who had received anti- Helicobacter pylori therapy were genotyped using the variable number tandem repeat (VNTR) method. Patients with an exacerbation of peptic ulcer disease and those wth an exacerbation of chronic pancreatitis with concomitant gastritis were compared from the level of acid production and from the belonging of Helicobacter pylori to virulent strains. Results. Patients with mild chronic gastritis were observed to have an abundance of nonvirulent allelic combination of vacAs2m2, which differed significantly from its frequency in both the patients with severe chronic gastritis and those with peptic ulcer disease. In the latter patients, the differences between the background bacteriological pattern and the pattern observed after 1.5–2 months had a high degree of significance; in these follow-up periods, in contrast to the control immediately after therapy, the number of eradications increased and the number of cagA-containing strains decreased due to the change of strains. Acid production was significantly higher in the patients with peptic ulcer disease than in those with chronic pancreatits and concomitant gastritis; the former patients show a statistically significant predominance of virulent strains; the latter patients had nonvirulent strains (at the same rate of Helicobacter pylori detection). Conclusion. Filling the blank spots in the study of helicobacteriosis remains relevant due to the progress of genetic methods in bacteriology and to the introduction of novel approaches to assessing the results of anti- Helicobacter pylori therapy.","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135827189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interferon-Gamma: Treatment Horizons. 干扰素- γ:治疗视野。
Q4 Medicine Pub Date : 2016-08-01
A A Khryanin, O V Reshetinikov

The review provides modern literature data on the system of interferons, their cells producers and target cells. Particular attention is paid to the immunomodulating effect of interferon-y. High efficacy of Ingaron in the treatment of various groups of diseases, especially viral, infectious and oncologic is shown.

本文综述了干扰素系统、干扰素产生细胞和干扰素靶细胞的现代文献资料。特别注意干扰素-y的免疫调节作用。英加龙在治疗各种疾病,特别是病毒性、感染性和肿瘤性疾病方面具有很高的疗效。
{"title":"Interferon-Gamma: Treatment Horizons.","authors":"A A Khryanin,&nbsp;O V Reshetinikov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The review provides modern literature data on the system of interferons, their cells producers and target cells. Particular attention is paid to the immunomodulating effect of interferon-y. High efficacy of Ingaron in the treatment of various groups of diseases, especially viral, infectious and oncologic is shown.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 ","pages":"35-40"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36198387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electrooptical Assay for Record of Antibiotic Action on Microbial Cells. 记录抗生素对微生物细胞作用的电光法。
Q4 Medicine Pub Date : 2016-08-01
O I Guliy, V D Bunin, O V Ignatov

Development of rapid and sensitive procedures for determination of microbial resistance to antibiotics is one of the most urgent trends in microbiology. The problem is shown to be solved by using electrooptical assay based on change of the electrophysical properties of suspended bacterial cells exposed to antibiotics with different mechanisms of action. Possible determination of the microbial cell susceptibility to antibiotics and their antibacterial activity is demonstrated. The results showed the procedure of electrooptical assay to be prospective in solving the problem of the microbiol cells antibiotic susceptibility in microbiology, medicine and veterinary.

开发快速和灵敏的方法来测定微生物对抗生素的耐药性是微生物学最紧迫的趋势之一。该问题可以通过使用基于不同作用机制的抗生素对悬浮细菌细胞电物理性质变化的光电检测来解决。证明了微生物细胞对抗生素的敏感性及其抗菌活性的可能测定。结果表明,该方法在解决微生物学、医学和兽医学中微生物细胞药敏问题方面具有广阔的应用前景。
{"title":"Electrooptical Assay for Record of Antibiotic Action on Microbial Cells.","authors":"O I Guliy,&nbsp;V D Bunin,&nbsp;O V Ignatov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Development of rapid and sensitive procedures for determination of microbial resistance to antibiotics is one of the most urgent trends in microbiology. The problem is shown to be solved by using electrooptical assay based on change of the electrophysical properties of suspended bacterial cells exposed to antibiotics with different mechanisms of action. Possible determination of the microbial cell susceptibility to antibiotics and their antibacterial activity is demonstrated. The results showed the procedure of electrooptical assay to be prospective in solving the problem of the microbiol cells antibiotic susceptibility in microbiology, medicine and veterinary.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 ","pages":"3-13"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36198871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children. 儿童化脓性链球菌对大环内酯类药物的耐药性及其分子遗传机制。
Q4 Medicine Pub Date : 2016-08-01
L K Katosova, A V Lazareva, T A Khokhlova, O A Ponomarenko, N M Alyabieva

The frequency and mechanisms of resistance to macrolides in Streptococcus.pyogenes isolated within 3 periods: 2011-2012 (246 strains), 2013-2014 (273 strains) and from January to November of 2015 (120 strains) were studied. The strains of S.pyogenes (639) were isolated from 17107 nasopharyngeal, vaginal and middle ear discharge smears of children on their visits to physiciants or hospitalization at somatic hospital departments. The susceptibility was tested by the disk diffusion method and E-test strips. Identification of the mechanisms of resistance to macrolides and lincosamides included phenotypic and molecular genetic methods. PCR was used to determine ermB and mef genes in 23 erythromycin resistant isolates. As compared to 2011-2012, resistance of S.pyogenes to macrolides increased from 5 to 16% in 2015 and that to clindamycin from 2 to 10%. Among 23 erythromycin resistant strains 6 (26.1%) belonged to the M phenotype, 3 (13.0%) belonged to the iMLS(b) phenotype and 14 (60.9%) belonged to the cMLS(b) pheno-type. The results of detecting the macrolide resistance genes in S.pyogenes showed that only 26.1% of the isolates expressed the mefA gene. The predominant share (65.2%) of the erythromycin resistant isolates possesed the ermB gene as a determinant and in 4.3% of the isolates the ermB gene was associatied with the mefgene. No resistance genes were detected 1 isolate. Therefore, the main mech- anism that determined resistance of S.pyogenes to macrolides was methylation of ribosomes mediated by the ermB gene.

链球菌对大环内酯类药物耐药的频率和机制。研究了2011-2012年(246株)、2013-2014年(273株)和2015年1- 11月(120株)3个时期分离的化脓菌。从医院内科就诊或住院儿童鼻咽、阴道和中耳分泌物涂片中分离到化脓性链球菌639株。采用纸片扩散法和e试纸条进行药敏试验。对大环内酯类和林肯胺类耐药机制的鉴定包括表型和分子遗传学方法。采用PCR检测23株红霉素耐药菌株的ermB和mef基因。与2011-2012年相比,2015年化脓性链球菌对大环内酯类药物的耐药率从5%上升到16%,对克林霉素的耐药率从2%上升到10%。23株红霉素耐药菌株中,M型6株(26.1%),iMLS(b)型3株(13.0%),cMLS(b)型14株(60.9%)。化脓性葡萄球菌大环内酯类耐药基因检测结果显示,仅有26.1%的菌株表达mefA基因。65.2%的耐药菌株以ermB基因为决定因素,4.3%的菌株中ermB基因与megene相关。1株分离物未检出耐药基因。因此,决定化脓性葡萄球菌对大环内酯类耐药的主要机制是ermB基因介导的核糖体甲基化。
{"title":"Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.","authors":"L K Katosova,&nbsp;A V Lazareva,&nbsp;T A Khokhlova,&nbsp;O A Ponomarenko,&nbsp;N M Alyabieva","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The frequency and mechanisms of resistance to macrolides in Streptococcus.pyogenes isolated within 3 periods: 2011-2012 (246 strains), 2013-2014 (273 strains) and from January to November of 2015 (120 strains) were studied. The strains of S.pyogenes (639) were isolated from 17107 nasopharyngeal, vaginal and middle ear discharge smears of children on their visits to physiciants or hospitalization at somatic hospital departments. The susceptibility was tested by the disk diffusion method and E-test strips. Identification of the mechanisms of resistance to macrolides and lincosamides included phenotypic and molecular genetic methods. PCR was used to determine ermB and mef genes in 23 erythromycin resistant isolates. As compared to 2011-2012, resistance of S.pyogenes to macrolides increased from 5 to 16% in 2015 and that to clindamycin from 2 to 10%. Among 23 erythromycin resistant strains 6 (26.1%) belonged to the M phenotype, 3 (13.0%) belonged to the iMLS(b) phenotype and 14 (60.9%) belonged to the cMLS(b) pheno-type. The results of detecting the macrolide resistance genes in S.pyogenes showed that only 26.1% of the isolates expressed the mefA gene. The predominant share (65.2%) of the erythromycin resistant isolates possesed the ermB gene as a determinant and in 4.3% of the isolates the ermB gene was associatied with the mefgene. No resistance genes were detected 1 isolate. Therefore, the main mech- anism that determined resistance of S.pyogenes to macrolides was methylation of ribosomes mediated by the ermB gene.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 ","pages":"23-29"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36198875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy. 他莫昔芬除雌激素受体外的分子靶点及其临床意义的新研究。
Q4 Medicine Pub Date : 2016-08-01
T A Bogush, B B Polezhaev, E A Dudko, E A Bogush, V Yu Kirsanov, B E Polotsky, S A Tjuljandin, M I Davydov

Tamoxifen is the first target agent with a high-end position in breast cancer therapy till now. In recent years experimental researches revealed new biological effects of tamoxifen on tumor cells. The present study continues the theme of the review published in 2012, where a plenty of tamoxifen effects besides interaction with estrogen receptors was discussed. Thus, there is described a wide range of the drug targets which are the key points of signal cascades activating the cell proliferation and determining the course of the growth of the cancer and its sensitivity to chemotherapy. Also clinical trials of tamoxifen based on existing of targets besides the estrogen receptors are reviewed. Furthermore, the data on the antiviral, antibacterial, antifungal and antiparasitic activities of tamoxifen are indicated.

他莫昔芬是迄今为止在乳腺癌治疗中第一个具有高端地位的靶向药物。近年来的实验研究揭示了他莫昔芬对肿瘤细胞的新的生物学效应。本研究延续了2012年发表的综述的主题,其中讨论了他莫昔芬除了与雌激素受体相互作用外的许多作用。因此,广泛的药物靶点被描述为信号级联反应的关键点,这些信号级联反应激活细胞增殖,决定肿瘤的生长过程及其对化疗的敏感性。综述了他莫昔芬除雌激素受体外的其他靶点的临床试验。此外,还介绍了他莫昔芬的抗病毒、抗菌、抗真菌和抗寄生虫活性。
{"title":"New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy.","authors":"T A Bogush,&nbsp;B B Polezhaev,&nbsp;E A Dudko,&nbsp;E A Bogush,&nbsp;V Yu Kirsanov,&nbsp;B E Polotsky,&nbsp;S A Tjuljandin,&nbsp;M I Davydov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Tamoxifen is the first target agent with a high-end position in breast cancer therapy till now. In recent years experimental researches revealed new biological effects of tamoxifen on tumor cells. The present study continues the theme of the review published in 2012, where a plenty of tamoxifen effects besides interaction with estrogen receptors was discussed. Thus, there is described a wide range of the drug targets which are the key points of signal cascades activating the cell proliferation and determining the course of the growth of the cancer and its sensitivity to chemotherapy. Also clinical trials of tamoxifen based on existing of targets besides the estrogen receptors are reviewed. Furthermore, the data on the antiviral, antibacterial, antifungal and antiparasitic activities of tamoxifen are indicated.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 ","pages":"41-49"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36198388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental Substantiation of Taurine Use in Prophylaxis of Isoniazid-Induced Neurotoxic Reactions. 牛磺酸预防异烟肼引起的神经毒性反应的实验证实。
Q4 Medicine Pub Date : 2016-08-01
G N Mozhokina, N A Elistratova

The effect of taurine and vitamin B6 on the clinical process and mortality of experimental mice due to isoniazid was studied in an acute test. The use of taurine lowered the toxic effect of isoniazid, evident from delayed covulsions, their shorter time, rarer repeat and lower mortality of the animals due to tonoclonic spasm. The most significant decrease of the neurotoxic effect of isoniazid was observed with the use of taurine in a dose of 255 mg/kg. When taurine in the dose of 255 mg/kg was used in combination with vitamin B6 in prophylactic doses of 1.3 or 3.9 mg/kg, no death of the mice due to isoniazid in the acute test was recorded.

通过急性试验研究了牛磺酸和维生素B6对异烟肼致小鼠临床过程和死亡率的影响。牛磺酸的使用降低了异烟肼的毒性作用,这从迟发性惊厥、它们的时间更短、重复次数更少和由强直性痉挛引起的动物死亡率更低可见一斑。用255mg /kg剂量的牛磺酸对异烟肼的神经毒性作用的降低最为显著。以255mg /kg剂量的牛磺酸与预防剂量1.3或3.9 mg/kg的维生素B6联合使用,急性试验中未见异烟肼致小鼠死亡。
{"title":"Experimental Substantiation of Taurine Use in Prophylaxis of Isoniazid-Induced Neurotoxic Reactions.","authors":"G N Mozhokina,&nbsp;N A Elistratova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effect of taurine and vitamin B6 on the clinical process and mortality of experimental mice due to isoniazid was studied in an acute test. The use of taurine lowered the toxic effect of isoniazid, evident from delayed covulsions, their shorter time, rarer repeat and lower mortality of the animals due to tonoclonic spasm. The most significant decrease of the neurotoxic effect of isoniazid was observed with the use of taurine in a dose of 255 mg/kg. When taurine in the dose of 255 mg/kg was used in combination with vitamin B6 in prophylactic doses of 1.3 or 3.9 mg/kg, no death of the mice due to isoniazid in the acute test was recorded.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 ","pages":"19-22"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36198874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biologically Active Substances from Marine Hydrobionts with Antibacterial Activity in Composition of New Wound Dressings. 新型伤口敷料成分中具有抗菌活性的海洋水生生物活性物质。
Q4 Medicine Pub Date : 2016-08-01
T A Kuznetsova, N N Besednova, T S Zaporozhets, N N Kovalev, V V Usov, A B Zemlyanoi

The data on the experimental study of the efficacy of the gel wound dressings based on chitosan and calcium alginate containing bioactive substances from marine hydrobionts with complex therapeutic action (sulfated polysaccharides from brown algae, hydrolyzed bivalves, peptides from nerve ganglia of cephalopods) are described. The model of thermal burns complicated by Staphylococcus aureus infection was used. Planimetric and bacteriological investigations revealed pronounced wound healing and antibacterial effects of the gel coating. The gel containing sulfated polysaccharides from brown algae showed the highest wound healing activity.

本文介绍了基于壳聚糖和海藻酸钙的凝胶伤口敷料的疗效实验研究数据,这些凝胶伤口敷料含有具有复杂治疗作用的海洋水生生物活性物质(褐藻硫酸化多糖、水解双壳贝类、头足类动物神经节肽)。使用了金黄色葡萄球菌感染并发热烧伤模型。平面测量和细菌学调查显示,凝胶涂层具有明显的伤口愈合和抗菌效果。含有褐藻硫酸化多糖的凝胶显示出最高的伤口愈合活性。
{"title":"Biologically Active Substances from Marine Hydrobionts with Antibacterial Activity in Composition of New Wound Dressings.","authors":"T A Kuznetsova, N N Besednova, T S Zaporozhets, N N Kovalev, V V Usov, A B Zemlyanoi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The data on the experimental study of the efficacy of the gel wound dressings based on chitosan and calcium alginate containing bioactive substances from marine hydrobionts with complex therapeutic action (sulfated polysaccharides from brown algae, hydrolyzed bivalves, peptides from nerve ganglia of cephalopods) are described. The model of thermal burns complicated by Staphylococcus aureus infection was used. Planimetric and bacteriological investigations revealed pronounced wound healing and antibacterial effects of the gel coating. The gel containing sulfated polysaccharides from brown algae showed the highest wound healing activity.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 ","pages":"14-18"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36198873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plant Extracts in Development of Medicinal Products of Various Therapeutic Value. 具有多种治疗价值的药用产品开发中的植物提取物。
Q4 Medicine Pub Date : 2016-08-01
I P Smirnova, O A Semkina, O V Bondarenko

Development, standardization and use of medicinal products of plant origin and various therapeutic value are described in the review. The literature data refer to the studies of some leading institutions of the Russian Federation and in particular to the Medical Institute of the Russian University of Peoples' Friendship, All-Russian Research Institute of Medicinal and Aromatic Plants, Pyatigorsk State Pharmaceutical Academy and some foreign laboratories. Possible use of the trichoderma extract and its prospects are shown.

综述了植物源性药材的开发、标准化和应用,以及各种治疗价值。文献数据指的是俄罗斯联邦一些主要机构的研究,特别是俄罗斯人民友谊大学医学研究所、全俄药用和芳香植物研究所、皮亚季戈尔斯克国家药学院和一些外国实验室的研究。展望了木霉提取物的应用前景。
{"title":"Plant Extracts in Development of Medicinal Products of Various Therapeutic Value.","authors":"I P Smirnova,&nbsp;O A Semkina,&nbsp;O V Bondarenko","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Development, standardization and use of medicinal products of plant origin and various therapeutic value are described in the review. The literature data refer to the studies of some leading institutions of the Russian Federation and in particular to the Medical Institute of the Russian University of Peoples' Friendship, All-Russian Research Institute of Medicinal and Aromatic Plants, Pyatigorsk State Pharmaceutical Academy and some foreign laboratories. Possible use of the trichoderma extract and its prospects are shown.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 ","pages":"30-34"},"PeriodicalIF":0.0,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36198876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of Sulfated Polysaccharides from Brown Alga Fucus evanescens and Their Enzymatic Transformation Product on Functional Activity of Innate Immunity Cells.] [来自褐藻 Fucus evanescens 的硫酸化多糖及其酶促转化产物对先天性免疫细胞功能活性的影响。]
Q4 Medicine Pub Date : 2016-01-01
T A Kuznetsova, T P Smolina, N N Besednova, A S Silchenko, T I Imbs, S P Ermakova

The effect of sulfated polysaccharides (PS) from brown alga Fucus evanescens and their enzymatic transformation and low molecular weight product on the functional activity of the innate immunity cells, i.e. polymorphonuclear leukocytes of human peripheral blood (NF) was comparatively studied. The in vitro NF contact with PS resulted in significant changes in the functional activity of NF, evident from higher density of molecules CD69, CD14, CD11b on the cell membranes with simultaneous lowering of that of CD62L and increased phagocytic and bactericidal activity of NF. The low molecular weight product resulting from fucoidan transformation with fucoidanases showed a higher effect on the level of the molecules CD14, CD11b and CD62L expression vs. the high molecular weight PS.

本研究比较研究了来自褐藻 Fucus evanescens 的硫酸化多糖(PS)及其酶转化和低分子量产物对先天性免疫细胞(即人体外周血多形核白细胞)功能活性的影响。体外 NF 与 PS 接触后,NF 的功能活性发生了显著变化,细胞膜上的 CD69、CD14、CD11b 分子密度升高,CD62L 分子密度降低,NF 的吞噬和杀菌活性增强。与高分子量 PS 相比,褐藻糖胶酶转化产生的低分子量产物对 CD14、CD11b 和 CD62L 分子的表达水平有更高的影响。
{"title":"[Effect of Sulfated Polysaccharides from Brown Alga Fucus evanescens and Their Enzymatic Transformation Product on Functional Activity of Innate Immunity Cells.]","authors":"T A Kuznetsova, T P Smolina, N N Besednova, A S Silchenko, T I Imbs, S P Ermakova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effect of sulfated polysaccharides (PS) from brown alga Fucus evanescens and their enzymatic transformation and low molecular weight product on the functional activity of the innate immunity cells, i.e. polymorphonuclear leukocytes of human peripheral blood (NF) was comparatively studied. The in vitro NF contact with PS resulted in significant changes in the functional activity of NF, evident from higher density of molecules CD69, CD14, CD11b on the cell membranes with simultaneous lowering of that of CD62L and increased phagocytic and bactericidal activity of NF. The low molecular weight product resulting from fucoidan transformation with fucoidanases showed a higher effect on the level of the molecules CD14, CD11b and CD62L expression vs. the high molecular weight PS.</p>","PeriodicalId":53646,"journal":{"name":"Antibiotiki i Khimioterapiya","volume":"61 7-8","pages":"10-14"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35908210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Antibiotiki i Khimioterapiya
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1